TrialScientific reports2017

HDL cholesterol efflux normalised to apoA-I is associated with future development of type 2 diabetes: from the CORDIOPREV trial.

Ruth Blanco-Rojo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.